Ads
related to: cost of herceptin cancer drug
Search results
Results from the WOW.Com Content Network
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. [ 31 ] [ 28 ] [ 32 ] [ 33 ] It is specifically used for cancer that is HER2 receptor positive . [ 31 ]
Breast cancer Pfizer: $465 $401 $320 $247 $143 $58 epirubicin: Ellence Breast cancer Pfizer: $312 $367 $344 $216 trastuzumab: Herceptin HER2-positive metastatic breast cancer Genentech: $1,382 $1,287 $1,234 $747.2 $483.2 $424.8 $385.2 $346.7 $276 gemcitabine: Gemzar
Originally it cost £5,900 a month. [27] and NICE estimated it cost £166,000 per QALY [28] (well over the usual maximum). It has been funded by the English NHS Cancer Drugs Fund but in January 2015 it was proposed to remove it from the approved list. [29] After a secret discount was agreed by Roche the Cancer Drugs Fund will continue to fund ...
The price cap comes after years of public outcry about the soaring cost of prescription drugs, including cancer. ... on Medicare had out-of-pocket prescription drug costs exceeding $2,000 in 2021 ...
Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the topoisomerase I inhibitor deruxtecan (a derivative of exatecan). [11] [12] It is licensed for the treatment of breast cancer or gastric or gastroesophageal ...
For premium support please call: 800-290-4726 more ways to reach us
Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Ads
related to: cost of herceptin cancer drug